We are thrilled to announce that Huma, the cutting-edge global digital health technology company, has successfully raised $80 million in funding. With a mission to leverage AI for enhancing digital-first care delivery and research, Huma is dedicated to helping individuals lead longer and more fulfilling lives. The company's acclaimed Software as a Medical Device, boasting EU MDR Class IIb and US FDA Class II regulatory statuses, is a pioneering platform that transcends disease boundaries. It facilitates digital-first care for health systems, offers companion apps to aid patients throughout their treatment journeys, and enables virtual clinical trials to expedite research efforts. This latest funding injection will bolster Huma's relentless commitment to revolutionizing healthcare through innovation and technology. To delve deeper into Huma's groundbreaking initiatives, be sure to explore their website at www.huma.com.








